ferroptosis model (TargetMol)
96
Structured Review
TargetMol
ferroptosis model

Ferroptosis Model, supplied by TargetMol, used in various techniques. Bioz Stars score: 96/100, based on 122 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/throughput+screening/Ferroptosis+Compound+Library/pmc12354519-82-9-4
Average 96 stars, based on 122 article reviews

Ferroptosis Model, supplied by TargetMol, used in various techniques. Bioz Stars score: 96/100, based on 122 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/throughput+screening/Ferroptosis+Compound+Library/pmc12354519-82-9-4
Average 96 stars, based on 122 article reviews
ferroptosis model - by Bioz Stars,
2026-11
96/100 stars
Images
1) Product Images from "Exosomal circ_0093708 as a potential ferroptosis biomarker in cerebral ischemia–reperfusion injury"
Article Title: Exosomal circ_0093708 as a potential ferroptosis biomarker in cerebral ischemia–reperfusion injury
Journal: Frontiers in Neurology
doi: 10.3389/fneur.2025.1633393
Figure Legend Snippet: Mining of key genes for ferroptosis and verification in external databases. (A) The 5-set Venn diagram showing the comprehensive strategy among suppressor ferroptosis-associated genes (green circle), unclassified ferroptosis-associated genes (orange circle), marker ferroptosis-associated genes (blue circle), driver ferroptosis-associated genes (pink circle), and differentially expressed genes (DEGs) (purple circle). (B) ROC analysis for DUSP1 in the discovery dataset. (C) ROC analysis for PTGS2 in the discovery dataset. (D) ROC analysis for DUSP1 in the validation dataset. (E) ROC analysis for PTGS2 in the validation dataset. ROC, receiver operating characteristic.
Techniques Used: Marker, Biomarker Discovery
Figure Legend Snippet: Inhibition of DUSP1 exacerbates ferroptosis in PC12 cells. (A) Cell viability after CIL56 treatment. (B) Intracellular MDA levels. (C) Effect of BCI on DUSP1 inhibition in the ferroptosis model. (D) Intracellular ROS levels (scale bar: 20 μm). (E) Protein expression of DUSP1, GPX4, and TFRC. (F) Quantification of GPX4 levels. (G) Quantification of TFRC levels. Data were analyzed by one-way ANOVA with Tukey’s post hoc test and presented as mean ± SD. Con, control.
Techniques Used: Inhibition, Expressing, Control
Related Articles
other:Article Title: Direct coupling and protective activation of DRP1 by the DNA-PKcs inhibitor KU-57788 synergizes with ferroptosis in anaplastic thyroid cancer cells. Article Snippet: 8505C and Hth-7 cells were treated with KU-57788 for 24 hours, then harvested and fixed with an electron microscope fixative (HaoKe Biotechnology Co. Ltd, China). Article Title: MXD4 enhances resistance to KRAS G12C-targeted therapy in lung adenocarcinoma by suppressing ACSL4-mediated ferroptosis. Article Snippet: A range of reagents was procured from various suppliers, including KRAS G12C inhibitors such as Cell Culture:Article Title: Psychological stress drives aging-like hematopoietic stem cell dysfunction through a brain-gut-bone marrow axis. Article Snippet: Article Psychological stress drives aging-like hematopoietic stem cell dysfunction through a brain-gut-bone marrow axis Cell Viability Assay:Article Title: Inhibition of the lipocalin-2-phosphatidylserine axis restores natural killer cell immune surveillance. Article Snippet: Ferroptosis induction and cell viability assay Cell viability was assessed using a Cell Counting Kit-8 (CCK8, TargetMol, C0005). .. CCK-8 Assay:Article Title: Inhibition of the lipocalin-2-phosphatidylserine axis restores natural killer cell immune surveillance. Article Snippet: Ferroptosis induction and cell viability assay Cell viability was assessed using a Cell Counting Kit-8 (CCK8, TargetMol, C0005). .. |